| 1. | Non - small cell lung cancer , nsclc
目的探讨氨基酸肠外营养对非小细胞肺癌 |
| 2. | Keyword : zd1839 nsclc disease control rates adverse events
关键词： zd1839非小细胞肺癌控制率不良事件。 |
| 3. | Keyword : zd1839 nsclc disease control rates adverse events
关键词： zd1839非小细胞肺癌疾病控制率不良事件。 |
| 4. | Keyword : zd1839 nsclc disease control rates adverse events
关键词： zd1839非小细胞肺癌症和肿瘤疾病控制率不良事件。 |
| 5. | Now it is mainly used as second - line or third - line therapy for nsclc in many countries
目前它主要用于终末期非小细胞肺癌的二线和三线治疗。 |
| 6. | Detection of micrometastasic tumor cells in lymphadenectomy specimens of patients with nsclc by real - time rt - pcr
技术检测肺癌淋巴结的隐匿性微小转移 |
| 7. | Objective to explore the nursing of harmful side effects of alimta in treating terminal nsclc
目的探讨新药力比泰治疗晚期非小细胞肺癌毒副反应的对症护理措施。 |
| 8. | We developed a five - gene signature that is closely associated with survival of patients with nsclc
我们发现了一个五基因标记与非小细胞肺癌的生存率有密切的关系。 |
| 9. | Background ： current staging methods are inadequate for predicting the outcome of treatment of non ? small - cell lung cancer ( nsclc )
背景：目前的分期方法尚不足以预测非小细胞肺癌的治疗效果。 |
| 10. | Conclusions our five - gene signature is closely associated with relapse - free and overall survival among patients with nsclc
结论：我们的五个基因标记与非小细胞肺癌患者的无复发及总生存率密切相关。 |
